Ordering
Available Variants10 mg
CHA.44571-10mg
Price
€302.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.44571-10mg | €302.40 |
≥95%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C21H16ClF3N4O4 |
|---|---|
| CAS Number | 583840-03-3 |
| Molecular Weight | 480.82 |
| MDL number | MFCD25974057 |
| NACRES | NA.21 |
| Assay | ≥95% |
| Form | powder or crystals |
| Solubility | DMSO: soluble, methanol: soluble |
Safety Information Handling visibility
| Storage Class | 10 - Combustible liquids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Sorafenib N-oxide, with a CAS number of 284461-73-0, is a significant metabolite of sorafenib, a multikinase inhibitor used in the treatment of various cancers, including renal cell carcinoma and hepatocellular carcinoma. The metabolic pathway of sorafenib involves oxidation to form sorafenib N-oxide, which is then further metabolized. This metabolite has been identified in human plasma and urine, indicating its importance in the pharmacokinetics of sorafenib. Studies have shown that sorafenib N-oxide retains some of the pharmacological activity of the parent compound, although its potency is reduced. Understanding the metabolism and pharmacology of sorafenib N-oxide is crucial for optimizing the therapeutic efficacy and minimizing the adverse effects of sorafenib. Further research is needed to fully elucidate the role of sorafenib N-oxide in the clinical effects of sorafenib.
